Status:
UNKNOWN
Complications and the Influence of COVID-19 on Myocardial Function and Exercise Capacity
Lead Sponsor:
Polish Mother Memorial Hospital Research Institute
Conditions:
Covid19
Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
The subject of the study is the impact of COVID-19 on the indicators of myocardial efficiency and exercise capacity. As a result of the observed dependencies, it will be possible to start an appropria...
Detailed Description
About 100 adult patients hospitalized in the Department of Cardiology and Congenital Heart Diseases of Adults who had recovered from COVID-19 will be included in the study. Selected prognostic factors...
Eligibility Criteria
Inclusion
- Age equal to or older than 18 years
- infection with the SARS-CoV-2 in past medical history
- current hospitalization
Exclusion
- severe hypertension;
- unstable angina;
- acute pulmonary embolism;
- decompensated heart failure;
- recent myocardial infarction;
- unstable heart rhythm disturbances;
- acute myocarditis or pericarditis;
- active endocarditis;
- advanced atrioventricular block;
- diagnosis of cardiomyopathy (hypertrophic, dilated, restrictive, peripartum, arrhythmogenic)
- lysosomal storage disorders
- severe hyper- and hypothyroidism
- pregnancy and lactation
- chronic kidney disease (IV, V stadium according to NKF) and dialysis treatment
- documented neoplastic process
- the patient's inability to cooperate and/or provide informed consent to participate in a research
- alcohol and drug abuse
- active autoimmune disease
- treatment using immunosuppressants, cytostatic drugs, glucocorticosteroids, or antiretroviral drugs
- a history of bone marrow transplant or other organ transplant, treatment with blood products within the last 6 months
- active systemic infection
- HBV, HCV or HIV carrier or positive for HbS antigen or antibodies to HCV
- surgery or serious injury within the last month
- patients who did not express their informed consent to participate in the study
Key Trial Info
Start Date :
December 23 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 1 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04828629
Start Date
December 23 2020
End Date
January 1 2025
Last Update
April 3 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Heart Failure Unit; Department of Cardiology and Congenital Diseases of Adults, Polish Mother's Memorial Hospital Research Institute
Lodz, Polska, Poland, 93-338